Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The Parkinson’s disease trial page now displays the study record for the withdrawn ND0612 infusion study, including its treatment arms, participation criteria, study dates, and primary outcome measure.
    Difference
    41%
    Check dated 2026-11-07T13:47:33.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study page remains an error page.
    Difference
    0.2%
    Check dated 2026-10-31T14:22:28.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and links to updates and FAQs; the study record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-24T15:10:19.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:54:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:58:01.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, with the 403 HTML elements added. The detailed study content (drug names, conditions, eligibility criteria, and trial details) has been removed from the page.
    Difference
    17%
    Check dated 2026-09-19T22:21:23.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.